Meloxicam and Vimizim drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Meloxicam (meloxicam) and Vimizim (elosulfase alfa). Common drug interactions include pyrexia among females and vomiting among males.

The phase IV clinical study analyzes what interactions people have when they take Meloxicam and Vimizim. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Meloxicam?

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 68,017 Meloxicam users. Check the latest studies of Meloxicam.

What is Vimizim?

Vimizim has active ingredients of elosulfase alfa. eHealthMe is studying from 4,772 Vimizim users. Check the latest studies of Vimizim.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

33 people who take Meloxicam and Vimizim together, and have interactions are studied.

Meloxicam and Vimizim drug interactions.

What are the common drug interactions of Meloxicam and Vimizim, by gender? *:

female:

Pyrexia (fever)
Anxiety
Chest pain
Dizziness
Dyspnoea (difficult or laboured respiration)
Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
Panic attack
Phobia (fear)
Somnolence (a state of near-sleep, a strong desire for sleep)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)

male:

Vomiting
Anxiety
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Vision blurred
Tracheitis (an inflammation of the trachea)
Anaphylactic reaction (serious allergic reaction)
Asthma
Blood pressure increased
Chills (felling of cold)
Dysphagia (a condition in which swallowing is difficult or painful)

What are the common drug interactions of Meloxicam and Vimizim, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Anxiety
Chest pain
Dizziness
Dyspnoea (difficult or laboured respiration)
Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
Panic attack
Somnolence (a state of near-sleep, a strong desire for sleep)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Vision blurred
Vomiting

20-29:

n/a

30-39:

n/a

40-49:

Catheter site pain
Pyrexia (fever)
Dysphagia (a condition in which swallowing is difficult or painful)
Fatigue (feeling of tiredness)
Feeling cold
Infusion site erythema (reddening of the skin at infusion site)
Infusion site pruritus (severe itching at infusion site)
Infusion site swelling
Infusion site urticaria (rash of round, red welts on the skin at infusion site)
Muscle tightness

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Hypersensitivity: 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Meloxicam and Vimizim?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously